Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial
Authors:
Open Access
- 14 December 2022
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 28 (46) , 6573-6588
Abstract
Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trialKeywords
This publication has 49 references indexed in Scilit:
- Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled studyAlimentary Pharmacology & Therapeutics, 2011
- Biopsychosocial Model of Irritable Bowel SyndromeJournal of Neurogastroenterology and Motility, 2011
- Efficacy of dioctahedral smectite in treating patients of diarrhea‐predominant irritable bowel syndromeJournal of Gastroenterology and Hepatology, 2007
- Antacid drug based on purified natural clinoptiloliteMicroporous and Mesoporous Materials, 2006
- Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trialAlimentary Pharmacology & Therapeutics, 2005
- Subject's Global Assessment of Relief: An appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trialsJournal of Clinical Epidemiology, 2003
- Validierung des “Perceived Stress Questionnaire“ (PSQ) an einer deutschen StichprobeDiagnostica, 2001
- Loperamide-Simethicone vs Loperamide Alone, Simethicone Alone, and Placebo in the Treatment of Acute Diarrhea With Gas-Related Abdominal Discomfort: A Randomized Controlled TrialArchives of Family Medicine, 1999
- A Double-Blind Placebo-Controlled Trial with Loperamide in Irritable Bowel SyndromeScandinavian Journal of Gastroenterology, 1996
- Role of loperamide and placebo in management of irritable bowel syndrome (IBS)Digestive Diseases and Sciences, 1984